28 June 2010
Kidney transplantation in Afghan refugees residing in Iran: The first report of survival analysis
Maryam Moghani-Lankarani, Shervin Assari, Babak Kardavani, Behzad EinollahAnn Transplant 2010; 15(2): 55-60 :: ID: 880941
Abstract
Background: We report, for the first time, the data on the outcome of kidney transplantation activities in the Afghan population from Iran.
Material/Method: We extracted the demographic, clinical and the outcome related data of all Afghan kidney transplanted patients, from 1998 to April 2006, from the United Nations High Commissioner for Refugees (UNHCR) and the Dialysis and Transplant Patients Association (DATPA) databases.
Results: During this period 103 Afghan patients (70.9% male, 29.1% female) underwent renal transplantation in Iran. The mean age at transplantation was 32.7 years. The kidney sources were living unrelated donors (LURD) in 82.5%, living related donors (LRD) in 15.5% and cadaver in 2% patients. The graft and patient survival rates for 1, 3 and 5 years were 97 and 98, 86 and 95, 73 and 95 percent, respectively.
Conclusions: Both graft and patient survival rates were good and comparable to those reported previously in Iranian patients.
Keywords: Kidney Transplantation, Refugees, Outcome
In Press
Original article
Common Versus External Iliac Arterial Anastomosis in Kidney Transplantation: A Bicentric Retrospective Anal...Ann Transplant In Press; DOI: 10.12659/AOT.953269
Original article
Protective Effects of Quercetin and Sucrose on Cold Preservation Injury in Porcine Kidneys Donated After Ca...Ann Transplant In Press; DOI: 10.12659/AOT.952503
Original article
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952888
Original article
Determinants of Lack of Consent for Deceased Organ Donation Among Nurses and Physicians: A Cross-Sectional ...Ann Transplant In Press; DOI: 10.12659/AOT.953598
Most Viewed Current Articles
24 Aug 2021 : Review article 21,160
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,335
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,325
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,249
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






